|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2011-9-2
|
|
pubmed:abstractText |
Several investigations have suggested that abnormalities in glutamate neural transmission play a role in the pathophysiology of psychiatric disorders, including schizophrenia. The metabotropic glutamate 3 receptor (mGluR3) gene was reported to be associated with schizophrenia, and paranoid type schizophrenia has symptoms that are similar to those of methamphetamine-induced psychosis. This suggests that mGluR3 gene (GRM3) is a good candidate gene for the pathogenesis of methamphetamine-induced psychosis. To evaluate the association between GRM3 and methamphetamine-induced psychosis, we conducted a case-control study of Japanese samples (181 methamphetamine-induced psychosis and 232 controls).
|
|
pubmed:commentsCorrections |
http://linkedlifedata.com/resource/pubmed/commentcorrection/21886583-15310849,
http://linkedlifedata.com/resource/pubmed/commentcorrection/21886583-17828217,
http://linkedlifedata.com/resource/pubmed/commentcorrection/21886583-18256595,
http://linkedlifedata.com/resource/pubmed/commentcorrection/21886583-18614340,
http://linkedlifedata.com/resource/pubmed/commentcorrection/21886583-18804497,
http://linkedlifedata.com/resource/pubmed/commentcorrection/21886583-18991851,
http://linkedlifedata.com/resource/pubmed/commentcorrection/21886583-19224106,
http://linkedlifedata.com/resource/pubmed/commentcorrection/21886583-19428704,
http://linkedlifedata.com/resource/pubmed/commentcorrection/21886583-19571598,
http://linkedlifedata.com/resource/pubmed/commentcorrection/21886583-19747927,
http://linkedlifedata.com/resource/pubmed/commentcorrection/21886583-20178807,
http://linkedlifedata.com/resource/pubmed/commentcorrection/21886583-6860719,
http://linkedlifedata.com/resource/pubmed/commentcorrection/21886583-9915503
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:status |
PubMed-not-MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
1875-6190
|
|
pubmed:author |
pubmed-author:IkedaMasashiM,
pubmed-author:InadaToshiyaT,
pubmed-author:IwataNakaoN,
pubmed-author:IyoMasaomiM,
pubmed-author:KawashimaKunihiroK,
pubmed-author:KinoshitaYokoY,
pubmed-author:KishiTaroT,
pubmed-author:KitajimaTsuyoshiT,
pubmed-author:OkochiTomoT,
pubmed-author:OkumuraTakenoriT,
pubmed-author:OzakiNorioN,
pubmed-author:SoraIchiroI,
pubmed-author:TsunokaTomokoT,
pubmed-author:UchimuraNaohisaN,
pubmed-author:UjikeHiroshiH,
pubmed-author:YamadaMitsuhikoM,
pubmed-author:YamanouchiYoshioY
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
9
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
160-2
|
|
pubmed:year |
2011
|
|
pubmed:articleTitle |
No Association Between GRM3 and Japanese Methamphetamine-Induced Psychosis.
|
|
pubmed:affiliation |
Department of Psychiatry, Fujita Health University School of Medicine, Toyoake, Aichi 470-1192, Japan.
|
|
pubmed:publicationType |
Journal Article
|
